Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Gold metabolism in patients with rheumatoid arthritis treated with gold compounds--reinvestigated.

× No keyword cloud information.

29 in total

1. Distribution of gold among plasma fractions in rheumatoid patients undergoing chrysotherapy compared with its distribution in plasma incubated with aurothiomalate in vitro.

Authors: C J Danpure; D A Fyfe; J M Gumpel
Journal: Ann Rheum Dis Date: 1979-08 Impact factor: 19.103

2. Binding of sodium aurothiomalate to human serum albumin in vitro at physiological conditions.

Authors: S M Pedersen
Journal: Ann Rheum Dis Date: 1986-09 Impact factor: 19.103

3. Thiol-containing compounds inhibit the production of monocyte/macrophage-derived angiogenic activity.

Authors: A E Koch; J C Burrows; P J Polverini; M Cho; S J Leibovich
Journal: Agents Actions Date: 1991-11

4. The inhibitory effect of disease-modifying anti-rheumatic drugs and steroids on gliostatin/platelet-derived endothelial cell growth factor production in human fibroblast-like synoviocytes.

Authors: Takuma Kusabe; Yuko Waguri-Nagaya; Tomohiro Tanikawa; Mineyoshi Aoyama; Muneyoshi Fukuoka; Masaaki Kobayashi; Takanobu Otsuka; Kiyofumi Asai
Journal: Rheumatol Int Date: 2005-07-01 Impact factor: 2.631

Review 5. Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future.

Authors: Rochelle R Arvizo; Sanjib Bhattacharyya; Rachel A Kudgus; Karuna Giri; Resham Bhattacharya; Priyabrata Mukherjee
Journal: Chem Soc Rev Date: 2012-03-05 Impact factor: 54.564

Review 6. Auranofin. A preliminary review of its pharmacological properties and therapeutic use in rheumatoid arthritis.

Authors: M Chaffman; R N Brogden; R C Heel; T M Speight; G S Avery
Journal: Drugs Date: 1984-05 Impact factor: 9.546

7. Free thiomalate levels in patients with rheumatoid arthritis treated with disodium aurothiomalate: relationship to clinical outcome of therapy.

Authors: S R Rudge; D Perrett; A J Swannell
Journal: Ann Rheum Dis Date: 1984-10 Impact factor: 19.103

8. Comparative pharmacokinetics of triethylphosphine gold (auranofin) and gold sodium thiomalate (GST).

Authors: D E Furst; S H Dromgoole
Journal: Clin Rheumatol Date: 1984-03 Impact factor: 2.980

9. Immunomodulatory effects of therapeutic gold compounds. Gold sodium thiomalate inhibits the activity of T cell protein kinase C.

Authors: K Hashimoto; C E Whitehurst; T Matsubara; K Hirohata; P E Lipsky
Journal: J Clin Invest Date: 1992-06 Impact factor: 14.808

10. Auranofin. New oral gold compound for treatment of rheumatoid arthritis.

Authors: A E Finkelstein; D T Walz; V Batista; M Mizraji; F Roisman; A Misher
Journal: Ann Rheum Dis Date: 1976-06 Impact factor: 19.103